Metacrine (Series A)

Funding Details

Awarder

Inbox

Date Award

August 05, 2015

Vertical

Biotechnology

Funding URL

View Funding Page

Funding Amount:

$36,000,000

---

Company Info

Founding Year

2015

Founders

Neil McDonnell

Company Description

Metacrine is a privately-held biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.

Market

Metabolic Diseases

Location

San Diego, CA, USA

Coinvestors

ARCH Venture Partners, EcoR1 Capital, Polaris Partners

---

Links

• Website